Neurobiology of axonal transport defects in motor neuron diseases: Opportunities for translational research?

Neurobiology of Disease

Volumn 105, Issue , 2017, Pages 283-299

  De Vos, Kurt J ^a   Hafezparast, Majid ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

Amyotrophic lateral sclerosis; Axonal transport; Microtubules; Mitochondria; Molecular motors; Motor neuron disease; Neurodegeneration

Indexed keywords

ALPHA TUBULIN; DYNEIN ADENOSINE TRIPHOSPHATASE; KINESIN;

AMYOTROPHIC LATERAL SCLEROSIS; AXONAL TRANSPORT DEFECT; CELL COMPONENT; CELL MIGRATION; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOSOME; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; MICROTUBULE; MICROTUBULE STABILITY; MITOCHONDRIAL TRAFFICKING; MOTOR NEURON DISEASE; NERVE FIBER TRANSPORT; NEUROBIOLOGY; NEUROLOGIC DISEASE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; TRANSLATIONAL RESEARCH; ANIMAL; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES;

ANIMALS; AXONAL TRANSPORT; HUMANS; MOTOR NEURON DISEASE; NEUROBIOLOGY; TRANSLATIONAL MEDICAL RESEARCH;

EID: 85013650275     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2017.02.004     Document Type: Review

References (315)

1. Abel, O., Powell, J.F., Andersen, P.M., Al-Chalabi, A., ALSoD: a user-friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics. Hum. Mutat. 33 (2012), 1345–1351.
2. Ackerley, S., Grierson, A.J., Brownlees, J., Thornhill, P., Anderton, B.H., Leigh, P.N., Shaw, C.E., Miller, C.C., Glutamate slows axonal transport of neurofilaments in transfected neurons. J. Cell Biol. 150 (2000), 165–176.
3. Ackerley, S., Thornhill, P., Grierson, A.J., Brownlees, J., Anderton, B.H., Leigh, P.N., Shaw, C.E., Miller, C.C., Neurofilament heavy chain side arm phosphorylation regulates axonal transport of neurofilaments. J. Cell Biol. 161 (2003), 489–495.
4. Ackerley, S., et al. p38alpha stress-activated protein kinase phosphorylates neurofilaments and is associated with neurofilament pathology in amyotrophic lateral sclerosis. Mol. Cell. Neurosci. 26 (2004), 354–364.
5. Akella, J.S., Wloga, D., Kim, J., Starostina, N.G., Lyons-Abbott, S., Morrissette, N.S., Dougan, S.T., Kipreos, E.T., Gaertig, J., MEC-17 is an alpha-tubulin acetyltransferase. Nature 467 (2010), 218–222.
6. Alami, N.H., et al. Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. Neuron 81 (2014), 536–543.
7. Allen, S.P., Duffy, L.M., Shaw, P.J., Grierson, A.J., Altered age-related changes in bioenergetic properties and mitochondrial morphology in fibroblasts from sporadic amyotrophic lateral sclerosis patients. Neurobiol. Aging 36 (2015), 2893–2903.
8. Alper, J.D., Decker, F., Agana, B., Howard, J., The motility of axonemal dynein is regulated by the tubulin code. Biophys. J. 107 (2014), 2872–2880.
9. Anagnostou, G., Akbar, M.T., Paul, P., Angelinetta, C., Steiner, T.J., de Belleroche, J., Vesicle associated membrane protein B (VAPB) is decreased in ALS spinal cord. Neurobiol. Aging 31 (2010), 969–985.
10. Araki, E., et al. A novel DCTN1 mutation with late-onset parkinsonism and frontotemporal atrophy. Mov. Disord. 29 (2014), 1201–1204.
11. Atkin, T.A., MacAskill, A.F., Brandon, N.J., Kittler, J.T., Disrupted in Schizophrenia-1 regulates intracellular trafficking of mitochondria in neurons. Mol. Psychiatry, 16(122–4), 2011, 121.
12. Avraham, K.B., Schickler, M., Sapoznikov, D., Yarom, R., Groner, Y., Down's syndrome: abnormal neuromuscular junction in tongue of transgenic mice with elevated levels of human Cu/Zn-superoxide dismutase. Cell 54 (1988), 823–829.
13. Avraham, K.B., Sugarman, H., Rotshenker, S., Groner, Y., Down's syndrome: morphological remodelling and increased complexity in the neuromuscular junction of transgenic CuZn-superoxide dismutase mice. J. Neurocytol. 20 (1991), 208–215.
14. Baas, P.W., Deitch, J.S., Black, M.M., Banker, G.A., Polarity orientation of microtubules in hippocampal neurons: uniformity in the axon and nonuniformity in the dendrite. Proc. Natl. Acad. Sci. U. S. A. 85 (1988), 8335–8339.
15. Babic, M., Russo, G.J., Wellington, A.J., Sangston, R.M., Gonzalez, M., Zinsmaier, K.E., Miro's N-terminal GTPase domain is required for transport of mitochondria into axons and dendrites. J. Neurosci. 35 (2015), 5754–5771.
16. Baldwin, K.R., Godena, V.K., Hewitt, V.L., Whitworth, A.J., Axonal transport defects are a common phenotype in Drosophila models of ALS. Hum. Mol. Genet. 25 (2016), 2378–2392.
17. Bannwarth, S., et al. A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. Brain 137 (2014), 2329–2345.
18. Barten, D.M., et al. Hyperdynamic microtubules, cognitive deficits, and pathology are improved in tau transgenic mice with low doses of the microtubule-stabilizing agent BMS-241027. J. Neurosci. 32 (2012), 7137–7145.
19. Bendotti, C., Atzori, C., Piva, R., Tortarolo, M., Strong, M.J., DeBiasi, S., Migheli, A., Activated p38MAPK is a novel component of the intracellular inclusions found in human amyotrophic lateral sclerosis and mutant SOD1 transgenic mice. J. Neuropathol. Exp. Neurol. 63 (2004), 113–119.
20. Bettencourt da Cruz, A., Schwärzel, M., Schulze, S., Niyyati, M., Heisenberg, M., Kretzschmar, D., Disruption of the MAP1B-related protein FUTSCH leads to changes in the neuronal cytoskeleton, axonal transport defects, and progressive neurodegeneration in Drosophila. Mol. Biol. Cell 16 (2005), 2433–2442.
21. Bian, F., Nath, R., Sobocinski, G., Booher, R.N., Lipinski, W.J., Callahan, M.J., Pack, A., Wang, K.K., Walker, L.C., Axonopathy, tau abnormalities, and dyskinesia, but no neurofibrillary tangles in p25-transgenic mice. J. Comp. Neurol. 446 (2002), 257–266.
22. Bilsland, L.G., Sahai, E., Kelly, G., Golding, M., Greensmith, L., Schiavo, G., Deficits in axonal transport precede ALS symptoms in vivo. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 20523–20528.
23. Black, M.M., Axonal transport: the orderly motion of axonal structures. Methods Cell Biol. 131 (2016), 1–19.
24. van Blitterswijk, M., et al. TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia. Acta Neuropathol. 127 (2014), 397–406.
25. Bobrowska, A., Donmez, G., Weiss, A., Guarente, L., Bates, G., SIRT2 ablation has no effect on tubulin acetylation in brain, cholesterol biosynthesis or the progression of Huntington's disease phenotypes in vivo. PLoS One, 7, 2012, e34805.
26. Bommel, H., Xie, G., Rossoll, W., Wiese, S., Jablonka, S., Boehm, T., Sendtner, M., Missense mutation in the tubulin-specific chaperone E (Tbce) gene in the mouse mutant progressive motor neuronopathy, a model of human motoneuron disease. J. Cell Biol. 159 (2002), 563–569.
27. Bosco, D.A., et al. Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat. Neurosci. 13 (2010), 1396–1403.
28. Bozzo, F., Mirra, A., Carrì, M.T., Oxidative stress and mitochondrial damage in the pathogenesis of ALS: new perspectives. Neurosci. Lett. 636 (2016), 3–8.
29. Brickley, K., Stephenson, F.A., Trafficking kinesin protein (TRAK)-mediated transport of mitochondria in axons of hippocampal neurons. J. Biol. Chem. 286 (2011), 18079–18092.
30. Brickley, K., Smith, M.J., Beck, M., Stephenson, F.A., GRIF-1 and OIP106, members of a novel gene family of coiled-coil domain proteins: association in vivo and in vitro with kinesin. J. Biol. Chem. 280 (2005), 14723–14732.
31. Bruijn, L.I., et al. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18 (1997), 327–338.
32. Brunden, K.R., et al. Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy. J. Neurosci. 30 (2010), 13861–13866.
33. Cai, D., McEwen, D.P., Martens, J.R., Meyhofer, E., Verhey, K.J., Single molecule imaging reveals differences in microtubule track selection between Kinesin motors. PLoS Biol., 7, 2009, e1000216.
34. Carrì, M.T., Ferri, A., Battistoni, A., Famhy, L., Gabbianelli, R., Poccia, F., Rotilio, G., Expression of a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis induces mitochondrial alteration and increase of cytosolic Ca2 + concentration in transfected neuroblastoma SH-SY5Y cells. FEBS Lett. 414 (1997), 365–368.
35. Carrì, M.T., D'Ambrosi, N., Cozzolino, M., Pathways to mitochondrial dysfunction in ALS pathogenesis. Biochem. Biophys. Res. Commun., 2016, 10.1016/j.bbrc.2016.07.055.
36. Cartelli, D., et al. Microtubule alterations occur early in experimental parkinsonism and the microtubule stabilizer epothilone D is neuroprotective. Sci. Report., 3, 2013, 1837.
37. Cavalli, V., Kujala, P., Klumperman, J., Goldstein, L.S., Sunday Driver links axonal transport to damage signaling. J. Cell Biol. 168 (2005), 775–787.
38. Chen, R.W., Qin, Z.H., Ren, M., Kanai, H., Chalecka-Franaszek, E., Leeds, P., Chuang, D.M., Regulation of c-Jun N-terminal kinase, p38 kinase and AP-1 DNA binding in cultured brain neurons: roles in glutamate excitotoxicity and lithium neuroprotection. J. Neurochem. 84 (2003), 566–575.
39. Chen, X.J., Levedakou, E.N., Millen, K.J., Wollmann, R.L., Soliven, B., Popko, B., Proprioceptive sensory neuropathy in mice with a mutation in the dynein heavy chain 1 gene. J. Neurosci. 27 (2007), 14515–14524.
40. Chen, Y., Guan, Y., Liu, H., Wu, X., Yu, L., Wang, S., Zhao, C., Du, H., Wang, X., Activation of the Wnt/β-catenin signaling pathway is associated with glial proliferation in the adult spinal cord of ALS transgenic mice. Biochem. Biophys. Res. Commun. 420 (2012), 397–403.
41. Chen, Y., Guan, Y., Zhang, Z., Liu, H., Wang, S., Yu, L., Wu, X., Wang, X., Wnt signaling pathway is involved in the pathogenesis of amyotrophic lateral sclerosis in adult transgenic mice. Neurol. Res. 34 (2012), 390–399.
42. Chen, Y., et al. PINK1 and Parkin are genetic modifiers for FUS-induced neurodegeneration. Hum. Mol. Genet., ddw310, 2016, 10.1093/hmg/ddw310.
43. Ciani, L., Salinas, P.C., c-Jun N-terminal kinase (JNK) cooperates with Gsk3beta to regulate Dishevelled-mediated microtubule stability. BMC Cell Biol., 8, 2007, 27.
44. Citterio, A., et al. Variants in KIF1A gene in dominant and sporadic forms of hereditary spastic paraparesis. J. Neurol. 262 (2015), 2684–2690.
45. Clark, J.A., Yeaman, E.J., Blizzard, C.A., Chuckowree, J.A., Dickson, T.C., A case for microtubule vulnerability in amyotrophic lateral sclerosis: altered dynamics during disease. Front. Cell. Neurosci., 10, 2016, 204.
46. Corbo, M., Hays, A.P., Peripherin and neurofilament protein coexist in spinal spheroids of motor neuron disease. J. Neuropathol. Exp. Neurol. 51 (1992), 531–537.
47. Coyne, A.N., Siddegowda, B.B., Estes, P.S., Johannesmeyer, J., Kovalik, T., Daniel, S.G., Pearson, A., Bowser, R., Zarnescu, D.C., Futsch/MAP1B mRNA is a translational target of TDP-43 and is neuroprotective in a Drosophila model of amyotrophic lateral sclerosis. J. Neurosci. 34 (2014), 15962–15974.
48. Cozzolino, M., Pesaresi, M.G., Amori, I., Crosio, C., Ferri, A., Nencini, M., Carrì, M.T., Oligomerization of mutant SOD1 in mitochondria of motoneuronal cells drives mitochondrial damage and cell toxicity. Antioxid. Redox Signal. 11 (2009), 1547–1558.
49. Curti, D., Malaspina, A., Facchetti, G., Camana, C., Mazzini, L., Tosca, P., Zerbi, F., Ceroni, M., Amyotrophic lateral sclerosis: oxidative energy metabolism and calcium homeostasis in peripheral blood lymphocytes. Neurology 47 (1996), 1060–1064.
50. De Vos, K., Severin, F., Van Herreweghe, F., Vancompernolle, K., Goossens, V., Hyman, A., Grooten, J., Tumor necrosis factor induces hyperphosphorylation of kinesin light chain and inhibits kinesin-mediated transport of mitochondria. J. Cell Biol. 149 (2000), 1207–1214.
51. De Vos, K.J., et al. Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content. Hum. Mol. Genet. 16 (2007), 2720–2728.
52. De Vos, K.J., Grierson, A.J., Ackerley, S., Miller, C.C., Role of axonal transport in neurodegenerative diseases. Annu. Rev. Neurosci. 31 (2008), 151–173.
53. De Vos, K.J., Morotz, G.M., Stoica, R., Tudor, E.L., Lau, K.F., Ackerley, S., Warley, A., Shaw, C.E., Miller, C.C., VAPB interacts with the mitochondrial protein PTPIP51 to regulate calcium homeostasis. Hum. Mol. Genet. 21 (2012), 1299–1311.
54. Deinhardt, K., Salinas, S., Verastegui, C., Watson, R., Worth, D., Hanrahan, S., Bucci, C., Schiavo, G., Rab5 and Rab7 control endocytic sorting along the axonal retrograde transport pathway. Neuron 52 (2006), 293–305.
55. Delphin, C., et al. MAP6-F is a temperature sensor that directly binds to and protects microtubules from cold-induced depolymerization. J. Biol. Chem. 287 (2012), 35127–35138.
56. Deng, W., Garrett, C., Dombert, B., Soura, V., Banks, G., Fisher, E.M., van der Brug, M.P., Hafezparast, M., Neurodegenerative mutation in dynein alters its organization and dynein-dynactin and dynein-kinesin interactions. J. Biol. Chem. 285 (2010), 39922–39934.
57. Devon, R.S., et al. Als2-deficient mice exhibit disturbances in endosome trafficking associated with motor behavioral abnormalities. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 9595–9600.
58. Dewil, M., dela Cruz, V.F., Van Den Bosch, L., Robberecht, W., Inhibition of p38 mitogen activated protein kinase activation and mutant SOD1(G93A)-induced motor neuron death. Neurobiol. Dis. 26 (2007), 332–341.
59. Ding, C., Wu, Z., Huang, L., Wang, Y., Xue, J., Chen, S., Deng, Z., Wang, L., Song, Z., Chen, S., Mitofilin and CHCHD6 physically interact with Sam50 to sustain cristae structure. Sci. Report., 5, 2015, 16064.
60. Dompierre, J.P., Godin, J.D., Charrin, B.C., Cordelieres, F.P., King, S.J., Humbert, S., Saudou, F., Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation. J. Neurosci. 27 (2007), 3571–3583.
61. Drerup, C.M., Nechiporuk, A.V., JNK-interacting protein 3 mediates the retrograde transport of activated c-Jun N-terminal kinase and lysosomes. PLoS Genet., 9, 2013, e1003303.
62. Drum, B.M., Yuan, C., Li, L., Liu, Q., Wordeman, L., Santana, L.F., Oxidative stress decreases microtubule growth and stability in ventricular myocytes. J. Mol. Cell. Cardiol. 93 (2016), 32–43.
63. Ebbing, B., Mann, K., Starosta, A., Jaud, J., Schols, L., Schule, R., Woehlke, G., Effect of spastic paraplegia mutations in KIF5A kinesin on transport activity. Hum. Mol. Genet. 17 (2008), 1245–1252.
64. Ebneth, A., Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease. J. Cell Biol. 143 (1998), 777–794.
65. El-Kadi, A.M., Soura, V., Hafezparast, M., Defective axonal transport in motor neuron disease. J. Neurosci. Res. 85 (2007), 2557–2566.
66. El-Kadi, A.M., et al. The legs at odd angles (Loa) mutation in dynein ameliorates mitochondrial function in SOD1G93A mouse model for motor neuron disease. J. Biol. Chem. 285 (2010), 18627–18639.
67. Erlich, Y., Edvardson, S., Hodges, E., Zenvirt, S., Thekkat, P., Shaag, A., Dor, T., Hannon, G.J., Elpeleg, O., Exome sequencing and disease-network analysis of a single family implicate a mutation in KIF1A in hereditary spastic paraparesis. Genome Res. 21 (2011), 658–664.
68. Errico, A., Ballabio, A., Rugarli, E.I., Spastin, the protein mutated in autosomal dominant hereditary spastic paraplegia, is involved in microtubule dynamics. Hum. Mol. Genet. 11 (2002), 153–163.
69. Evans, K.J., Gomes, E.R., Reisenweber, S.M., Gundersen, G.G., Lauring, B.P., Linking axonal degeneration to microtubule remodeling by Spastin-mediated microtubule severing. J. Cell Biol. 168 (2005), 599–606.
70. Fallini, C., Bassell, G.J., Rossoll, W., The ALS disease protein TDP-43 is actively transported in motor neuron axons and regulates axon outgrowth. Hum. Mol. Genet. 21 (2012), 3703–3718.
71. Fan, Y., Wali, G., Sutharsan, R., Bellette, B., Crane, D.I., Sue, C.M., Mackay-Sim, A., Low dose tubulin-binding drugs rescue peroxisome trafficking deficit in patient-derived stem cells in Hereditary Spastic Paraplegia. Biol. Open 3 (2014), 494–502.
72. Fanara, P., Banerjee, J., Hueck, R.V., Harper, M.R., Awada, M., Turner, H., Husted, K.H., Brandt, R., Hellerstein, M.K., Stabilization of hyperdynamic microtubules is neuroprotective in amyotrophic lateral sclerosis. J. Biol. Chem. 282 (2007), 23465–23472.
73. Farah, C.A., Nguyen, M.D., Julien, J.P., Leclerc, N., Altered levels and distribution of microtubule-associated proteins before disease onset in a mouse model of amyotrophic lateral sclerosis. J. Neurochem. 84 (2003), 77–86.
74. Farrer, M.J., et al. DCTN1 mutations in Perry syndrome. Nat. Genet. 41 (2009), 163–165.
75. Feng, H.L., Leng, Y., Ma, C.H., Zhang, J., Ren, M., Chuang, D.M., Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model. Neuroscience 155 (2008), 567–572.
76. Ferraiuolo, L., The non-cell-autonomous component of ALS: new in vitro models and future challenges. Biochem. Soc. Trans. 42 (2014), 1270–1274.
77. Ferraiuolo, L., Kirby, J., Grierson, A.J., Sendtner, M., Shaw, P.J., Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat. Rev. Neurol. 7 (2011), 616–630.
78. Fichera, M., Lo Giudice, M., Falco, M., Sturnio, M., Amata, S., Calabrese, O., Bigoni, S., Calzolari, E., Neri, M., Evidence of kinesin heavy chain (KIF5A) involvement in pure hereditary spastic paraplegia. Neurology 63 (2004), 1108–1110.
79. Fransson, S., Ruusala, A., Aspenstrom, P., The atypical Rho GTPases Miro-1 and Miro-2 have essential roles in mitochondrial trafficking. Biochem. Biophys. Res. Commun. 344 (2006), 500–510.
80. Fu, M.M., Holzbaur, E.L., Integrated regulation of motor-driven organelle transport by scaffolding proteins. Trends Cell Biol. 24 (2014), 564–574.
81. Fumoto, K., Hoogenraad, C.C., Kikuchi, A., GSK-3beta-regulated interaction of BICD with dynein is involved in microtubule anchorage at centrosome. EMBO J. 25 (2006), 5670–5682.
82. Furukawa, K., Mattson, M.P., Taxol stabilizes [Ca2 +]i and protects hippocampal neurons against excitotoxicity. Brain Res. 689 (1995), 141–146.
83. Gal, J., Chen, J., Barnett, K.R., Yang, L., Brumley, E., Zhu, H., HDAC6 regulates mutant SOD1 aggregation through two SMIR motifs and tubulin acetylation. J. Biol. Chem. 288 (2013), 15035–15045.
84. Gallagher, M.D., et al. TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions. Acta Neuropathol. 127 (2014), 407–418.
85. Gao, F.J., Hebbar, S., Gao, X.A., Alexander, M., Pandey, J.P., Walla, M.D., Cotham, W.E., King, S.J., Smith, D.S., GSK-3β phosphorylation of dynein reduces Ndel1 binding to intermediate chains and alters dynein motility. Traffic 16 (2015), 941–961.
86. Garrett, C.A., Barri, M., Kuta, A., Soura, V., Deng, W., Fisher, E.M., Schiavo, G., Hafezparast, M., DYNC1H1 mutation alters transport kinetics and ERK1/2-cFos signalling in a mouse model of distal spinal muscular atrophy. Brain 137 (2014), 1883–1893.
87. Genin, E.C., et al. CHCHD10 mutations promote loss of mitochondrial cristae junctions with impaired mitochondrial genome maintenance and inhibition of apoptosis. EMBO Mol. Med. 8 (2016), 58–72.
88. Gentil, B.J., Tibshirani, M., Durham, H.D., Neurofilament dynamics and involvement in neurological disorders. Cell Tissue Res. 360 (2015), 609–620.
89. Ghazi-Noori, S., et al. Progressive neuronal inclusion formation and axonal degeneration in CHMP2B mutant transgenic mice. Brain 135 (2012), 819–832.
90. Gibbs, K.L., Greensmith, L., Schiavo, G., Regulation of axonal transport by protein kinases. Trends Biochem. Sci. 40 (2015), 597–610.
91. Gill, A., Kidd, J., Vieira, F., Thompson, K., Perrin, S., No benefit from chronic lithium dosing in a sibling-matched, gender balanced, investigator-blinded trial using a standard mouse model of familial ALS. PLoS One, 4, 2009, e6489.
92. Gilley, J., et al. Age-dependent axonal transport and locomotor changes and tau hypophosphorylation in a “P301L” tau knockin mouse. Neurobiol. Aging, 33(621), 2012, e1-621.e15.
93. Glater, E.E., Megeath, L.J., Stowers, R.S., Schwarz, T.L., Axonal transport of mitochondria requires milton to recruit kinesin heavy chain and is light chain independent. J. Cell Biol. 173 (2006), 545–557.
94. Godena, V.K., Romano, G., Romano, M., Appocher, C., Klima, R., Buratti, E., Baralle, F.E., Feiguin, F., TDP-43 regulates Drosophila neuromuscular junctions growth by modulating Futsch/MAP1B levels and synaptic microtubules organization. PLoS One, 6, 2011, e17808.
95. Godena, V.K., Brookes-Hocking, N., Moller, A., Shaw, G., Oswald, M., Sancho, R.M., Miller, C.C., Whitworth, A.J., De Vos, K.J., Increasing microtubule acetylation rescues axonal transport and locomotor deficits caused by LRRK2 Roc-COR domain mutations. Nat. Commun., 5, 2014, 5245.
96. Govindarajan, N., Rao, P., Burkhardt, S., Sananbenesi, F., Schluter, O.M., Bradke, F., Lu, J., Fischer, A., Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer's disease. EMBO Mol. Med. 5 (2013), 52–63.
97. Grosskreutz, J., Van Den Bosch, L., Keller, B.U., Calcium dysregulation in amyotrophic lateral sclerosis. Cell Calcium 47 (2010), 165–174.
98. Grundke-Iqbal, I., Iqbal, K., Quinlan, M., Tung, Y.-C., Zaidi, M., Wisniewski, H., Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J. Biol. Chem. 61 (1986), 6084–6089.
99. Guidato, S., Tsai, L.H., Woodgett, J., Miller, C.C., Differential cellular phosphorylation of neurofilament heavy side-arms by glycogen synthase kinase-3 and cyclin-dependent kinase-5. J. Neurochem. 66 (1996), 1698–1706.
100. Gustavsson, E.K., et al. DCTN1 p.K56R in progressive supranuclear palsy. Parkinsonism Relat. Disord. 28 (2016), 56–61.
101. Hadano, S., et al. Mice deficient in the Rab5 guanine nucleotide exchange factor ALS2/alsin exhibit age-dependent neurological deficits and altered endosome trafficking. Hum. Mol. Genet. 15 (2006), 233–250.
102. Hafezparast, M., et al. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 300 (2003), 808–812.
103. Halievski, K., Kemp, M.Q., Breedlove, S.M., Miller, K.E., Jordan, C.L., Non-Cell-Autonomous Regulation of Retrograde Motoneuronal Axonal Transport in an SBMA Mouse Model. eNeuro 3, ENEURO.0062-16.2016. 2016.
104. Hammond, J.W., Huang, C.F., Kaech, S., Jacobson, C., Banker, G., Verhey, K.J., Posttranslational modifications of tubulin and the polarized transport of kinesin-1 in neurons. Mol. Biol. Cell 21 (2010), 572–583.
105. Hanger, D.P., Noble, W., Functional implications of glycogen synthase kinase-3-mediated tau phosphorylation. Int. J. Alzheimers Dis., 2011, 2011, 352805.
106. Hazan, J., et al. Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia. Nat. Genet. 23 (1999), 296–303.
107. Hinckelmann, M.V., Virlogeux, A., Niehage, C., Poujol, C., Choquet, D., Hoflack, B., Zala, D., Saudou, F., Self-propelling vesicles define glycolysis as the minimal energy machinery for neuronal transport. Nat. Commun., 7, 2016, 13233.
108. Hirano, A., Donnenfeld, H., Sasaki, S., Nakano, I., Fine structural observations of neurofilamentous changes in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 43 (1984), 461–470.
109. Hirano, A., Nakano, I., Kurland, L.T., Mulder, D.W., Holley, P.W., Saccomanno, G., Fine structural study of neurofibrillary changes in a family with amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 43 (1984), 471–480.
110. Hirokawa, N., Niwa, S., Tanaka, Y., Molecular motors in neurons: transport mechanisms and roles in brain function, development, and disease. Neuron 68 (2010), 610–638.
111. Holasek, S.S., Wengenack, T.M., Kandimalla, K.K., Montano, C., Gregor, D.M., Curran, G.L., Poduslo, J.F., Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice. Brain Res. 1045 (2005), 185–198.
112. Horiuchi, D., Collins, C.A., Bhat, P., Barkus, R.V., Diantonio, A., Saxton, W.M., Control of a kinesin-cargo linkage mechanism by JNK pathway kinases. Curr. Biol. 17 (2007), 1313–1317.
113. Hu, J.H., Chernoff, K., Pelech, S., Krieger, C., Protein kinase and protein phosphatase expression in the central nervous system of G93A mSOD over-expressing mice. J. Neurochem. 85 (2003), 422–431.
114. Hu, J.H., Zhang, H., Wagey, R., Krieger, C., Pelech, S.L., Protein kinase and protein phosphatase expression in amyotrophic lateral sclerosis spinal cord. J. Neurochem. 85 (2003), 432–442.
115. Huang, S.H., Duan, S., Sun, T., Wang, J., Zhao, L., Geng, Z., Yan, J., Sun, H.J., Chen, Z.Y., JIP3 mediates TrkB axonal anterograde transport and enhances BDNF signaling by directly bridging TrkB with kinesin-1. J. Neurosci. 31 (2011), 10602–10614.
116. Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X.-F., Yao, T.P., HDAC6 is a microtubule-associated deacetylase. Nature 417 (2002), 455–458.
117. Igoudjil, A., Magrane, J., Fischer, L.R., Kim, H.J., Hervias, I., Dumont, M., Cortez, C., Glass, J.D., Starkov, A.A., Manfredi, G., In vivo pathogenic role of mutant SOD1 localized in the mitochondrial intermembrane space. J. Neurosci. 31 (2011), 15826–15837.
118. Ilieva, H.S., Yamanaka, K., Malkmus, S., Kakinohana, O., Yaksh, T., Marsala, M., Cleveland, D.W., Mutant dynein (Loa) triggers proprioceptive axon loss that extends survival only in the SOD1 ALS model with highest motor neuron death. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 12599–12604.
119. Iqbal, K., Liu, F., Gong, C.X., Tau and neurodegenerative disease: the story so far. Nat. Rev. Neurol. 12 (2016), 15–27.
120. Ishiguro, A., Kimura, N., Watanabe, Y., Watanabe, S., Ishihama, A., TDP-43 binds and transports G-quadruplex-containing mRNAs into neurites for local translation. Genes Cells 21 (2016), 466–481.
121. Israelson, A., Arbel, N., Da Cruz, S., Ilieva, H., Yamanaka, K., Shoshan-Barmatz, V., Cleveland, D.W., Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS. Neuron 67 (2010), 575–587.
122. Jaarsma, D., Holstege, J.C., Troost, D., Davis, M., Kennis, J., Haasdijk, E.D., de Jong, V.J., Induction of c-Jun immunoreactivity in spinal cord and brainstem neurons in a transgenic mouse model for amyotrophic lateral sclerosis. Neurosci. Lett. 219 (1996), 179–182.
123. Jeon, S.H., Kim, Y.S., Bae, C.D., Park, J.B., Activation of JNK and p38 in rat hippocampus after kainic acid induced seizure. Exp. Mol. Med. 32 (2000), 227–230.
124. Jimenez-Mateos, E.M., Gonzalez-Billault, C., Dawson, H.N., Vitek, M.P., Avila, J., Role of MAP1B in axonal retrograde transport of mitochondria. Biochem. J. 397 (2006), 53–59.
125. Job, D., Fischer, E.H., Margolis, R.L., Rapid disassembly of cold-stable microtubules by calmodulin. Proc. Natl. Acad. Sci. U. S. A. 78 (1981), 4679–4682.
126. John, G.B., Shang, Y., Li, L., Renken, C., Mannella, C.A., Selker, J.M., Rangell, L., Bennett, M.J., Zha, J., The mitochondrial inner membrane protein mitofilin controls cristae morphology. Mol. Biol. Cell 16 (2005), 1543–1554.
127. Jung, C., Lee, S., Ortiz, D., Zhu, Q., Julien, J.P., Shea, T.B., The high and middle molecular weight neurofilament subunits regulate the association of neurofilaments with kinesin: inhibition by phosphorylation of the high molecular weight subunit. Brain Res. Mol. Brain Res. 141 (2005), 151–155.
128. Kabuta, T., Kinugawa, A., Tsuchiya, Y., Kabuta, C., Setsuie, R., Tateno, M., Araki, T., Wada, K., Familial amyotrophic lateral sclerosis-linked mutant SOD1 aberrantly interacts with tubulin. Biochem. Biophys. Res. Commun. 387 (2009), 121–126.
129. Kardon, J.R., Vale, R.D., Regulators of the dynein motor. Nat. Rev. Mol. Cell Biol. 10 (2009), 854–865.
130. Kasher, P.R., et al. Direct evidence for axonal transport defects in a novel mouse model of mutant spastin-induced hereditary spastic paraplegia (HSP) and human HSP patients. J. Neurochem. 110 (2009), 34–44.
131. Katsuno, M., et al. Reversible disruption of dynactin 1-mediated retrograde axonal transport in polyglutamine-induced motor neuron degeneration. J. Neurosci. 26 (2006), 12106–12117.
132. Kawaguchi, Y., Kovacs, J.J., McLaurin, A., Vance, J.M., Ito, A., Yao, T.P., The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell 115 (2003), 727–738.
133. Kawasaki, H., Morooka, T., Shimohama, S., Kimura, J., Hirano, T., Gotoh, Y., Nishida, E., Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells. J. Biol. Chem. 272 (1997), 18518–18521.
134. Kieran, D., Hafezparast, M., Bohnert, S., Dick, J.R., Martin, J., Schiavo, G., Fisher, E.M., Greensmith, L., A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice. J. Cell Biol. 169 (2005), 561–567.
135. Kiernan, M.C., Vucic, S., Cheah, B.C., Turner, M.R., Eisen, A., Hardiman, O., Burrell, J.R., Zoing, M.C., Amyotrophic lateral sclerosis. Lancet 377 (2011), 942–955.
136. Kim, S.H., Shanware, N.P., Bowler, M.J., Tibbetts, R.S., Amyotrophic lateral sclerosis-associated proteins TDP-43 and FUS/TLS function in a common biochemical complex to co-regulate HDAC6 mRNA. J. Biol. Chem. 285 (2010), 34097–34105.
137. Kim, J.Y., Jang, A., Reddy, R., Hee Yoon, W., Jankowsky, J.L., Neuronal overexpression of human VAPB slows motor impairment and neuromuscular denervation in a mouse model of ALS. Hum. Mol. Genet., ddw294, 2016, 10.1093/hmg/ddw294.
138. King, S.M., Dyneins: Structure, Biology and Disease. 2012, Academic Press, Amsterdam; Boston.
139. Kleele, T., et al. An assay to image neuronal microtubule dynamics in mice. Nat. Commun., 5, 2014, 4827.
140. Klinman, E., Holzbaur, E.L., Stress-induced CDK5 activation disrupts axonal transport via Lis1/Ndel1/dynein. Cell Rep. 12 (2015), 462–473.
141. Koh, S.H., Lee, Y.B., Kim, K.S., Kim, H.J., Kim, M., Lee, Y.J., Kim, J., Lee, K.W., Kim, S.H., Role of GSK-3beta activity in motor neuronal cell death induced by G93A or A4V mutant hSOD1 gene. Eur. J. Neurosci. 22 (2005), 301–309.
142. Koh, S.H., Kim, Y., Kim, H.Y., Hwang, S., Lee, C.H., Kim, S.H., Inhibition of glycogen synthase kinase-3 suppresses the onset of symptoms and disease progression of G93A-SOD1 mouse model of ALS. Exp. Neurol. 205 (2007), 336–346.
143. Konishi, Y., Setou, M., Tubulin tyrosination navigates the kinesin-1 motor domain to axons. Nat. Neurosci. 12 (2009), 559–567.
144. Kratzer, E., Tian, Y., Sarich, N., Wu, T., Meliton, A., Leff, A., Birukova, A.A., Oxidative stress contributes to lung injury and barrier dysfunction via microtubule destabilization. Am. J. Respir. Cell Mol. Biol. 47 (2012), 688–697.
145. Kusakawa, G., Saito, T., Onuki, R., Ishiguro, K., Kishimoto, T., Hisanaga, S., Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25. J. Biol. Chem. 275 (2000), 17166–17172.
146. Lai, C., et al. Amyotrophic lateral sclerosis 2-deficiency leads to neuronal degeneration in amyotrophic lateral sclerosis through altered AMPA receptor trafficking. J. Neurosci. 26 (2006), 11798–11806.
147. Lai, C., Lin, X., Chandran, J., Shim, H., Yang, W.J., Cai, H., The G59S mutation in p150(glued) causes dysfunction of dynactin in mice. J. Neurosci. 27 (2007), 13982–13990.
148. Lai, C., Xie, C., Shim, H., Chandran, J., Howell, B.W., Cai, H., Regulation of endosomal motility and degradation by amyotrophic lateral sclerosis 2/alsin. Mol. Brain, 2, 2009, 23.
149. Laird, F.M., Farah, M.H., Ackerley, S., Hoke, A., Maragakis, N., Rothstein, J.D., Griffin, J., Price, D.L., Martin, L.J., Wong, P.C., Motor neuron disease occurring in a mutant dynactin mouse model is characterized by defects in vesicular trafficking. J. Neurosci. 28 (2008), 1997–2005.
150. LaMonte, B.H., Wallace, K.E., Holloway, B.A., Shelly, S.S., Ascano, J., Tokito, M., Van Winkle, T., Howland, D.S., Holzbaur, E.L., Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron 34 (2002), 715–727.
151. Lautenschlager, J., Prell, T., Ruhmer, J., Weidemann, L., Witte, O.W., Grosskreutz, J., Overexpression of human mutated G93A SOD1 changes dynamics of the ER mitochondria calcium cycle specifically in mouse embryonic motor neurons. Exp. Neurol. 247 (2013), 91–100.
152. Lee, M.S., Kwon, Y.T., Li, M., Peng, J., Friedlander, R.M., Tsai, L.H., Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405 (2000), 360–364.
153. Lee, S., Pant, H.C., Shea, T.B., Divergent and convergent roles for kinases and phosphatases in neurofilament dynamics. J. Cell Sci. 127 (2014), 4064–4077.
154. Lee, J.R., et al. De novo mutations in the motor domain of KIF1A cause cognitive impairment, spastic paraparesis, axonal neuropathy, and cerebellar atrophy. Hum. Mutat. 36 (2015), 69–78.
155. Lee, J.Y., Kawaguchi, Y., Li, M., Kapur, M., Choi, S.J., Kim, H.J., Park, S.Y., Zhu, H., Yao, T.P., Uncoupling of protein aggregation and neurodegeneration in a mouse amyotrophic lateral sclerosis model. Neurodegener. Dis. 15 (2015), 339–349.
156. Lee, S., et al. Activation of HIPK2 promotes ER stress-mediated neurodegeneration in amyotrophic lateral sclerosis. Neuron 91 (2016), 41–55.
157. Lefèvre, J., Savarin, P., Gans, P., Hamon, L., Clément, M.J., David, M.O., Bosc, C., Andrieux, A., Curmi, P.A., Structural basis for the association of MAP6 protein with microtubules and its regulation by calmodulin. J. Biol. Chem. 288 (2013), 24910–24922.
158. Letournel, F., Bocquet, A., Dubas, F., Barthelaix, A., Eyer, J., Stable tubule only polypeptides (STOP) proteins co-aggregate with spheroid neurofilaments in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 62 (2003), 1211–1219.
159. Levy, J.R., et al. A motor neuron disease-associated mutation in p150Glued perturbs dynactin function and induces protein aggregation. J. Cell Biol. 172 (2006), 733–745.
160. Li, Q., et al. ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein import. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 21146–21151.
161. Ligon, L.A., LaMonte, B.H., Wallace, K.E., Weber, N., Kalb, R.G., Holzbaur, E.L., Mutant superoxide dismutase disrupts dynein in motor neurons. Neuroreport 16 (2005), 533–536.
162. Lipka, J., Kuijpers, M., Jaworski, J., Hoogenraad, C.C., Mutations in dynein and its regulators cause malformations of cortical development and neurodegenerative diseases. Biochem. Soc. Trans. 41 (2013), 1605–1612.
163. Liu, J., et al. Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron 43 (2004), 5–17.
164. Llorens-Martín, M., Jurado, J., Hernández, F., Avila, J., GSK-3β, a pivotal kinase in Alzheimer disease. Front. Mol. Neurosci., 7, 2014, 46.
165. López, E., Casasnovas, C., Giménez, J., Santamaría, R., Terrazas, J.M., Volpini, V., Identification of two novel KIF5A mutations in hereditary spastic paraplegia associated with mild peripheral neuropathy. J. Neurol. Sci. 358 (2015), 422–427.
166. López-Doménech, G., Higgs, N.F., Vaccaro, V., Roš, H., Arancibia-Cárcamo, I.L., MacAskill, A.F., Kittler, J.T., Loss of dendritic complexity precedes neurodegeneration in a mouse model with disrupted mitochondrial distribution in mature dendrites. Cell Rep. 17 (2016), 317–327.
167. MacAskill, A.F., Brickley, K., Stephenson, F.A., Kittler, J.T., GTPase dependent recruitment of Grif-1 by Miro1 regulates mitochondrial trafficking in hippocampal neurons. Mol. Cell. Neurosci. 40 (2009), 301–312.
168. MacAskill, A.F., Rinholm, J.E., Twelvetrees, A.E., Arancibia-Carcamo, I.L., Muir, J., Fransson, A., Aspenstrom, P., Attwell, D., Kittler, J.T., Miro1 is a calcium sensor for glutamate receptor-dependent localization of mitochondria at synapses. Neuron 61 (2009), 541–555.
169. Magnani, E., Fan, J., Gasparini, L., Golding, M., Williams, M., Schiavo, G., Goedert, M., Amos, L.A., Spillantini, M.G., Interaction of tau protein with the dynactin complex. EMBO J. 26 (2007), 4546–4554.
170. Magrané, J., Hervias, I., Henning, M.S., Damiano, M., Kawamata, H., Manfredi, G., Mutant SOD1 in neuronal mitochondria causes toxicity and mitochondrial dynamics abnormalities. Hum. Mol. Genet. 18 (2009), 4552–4564.
171. Magrané, J., Sahawneh, M.A., Przedborski, S., Estevez, A.G., Manfredi, G., Mitochondrial dynamics and bioenergetic dysfunction is associated with synaptic alterations in mutant SOD1 motor neurons. J. Neurosci. 32 (2012), 229–242.
172. Magrané, J., Cortez, C., Gan, W.B., Manfredi, G., Abnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models. Hum. Mol. Genet. 23 (2014), 1413–1424.
173. Manser, C., Guillot, F., Vagnoni, A., Davies, J., Lau, K.F., McLoughlin, D.M., De Vos, K.J., Miller, C.C., Lemur tyrosine kinase-2 signalling regulates kinesin-1 light chain-2 phosphorylation and binding of Smad2 cargo. Oncogene 31 (2012), 2773–2782.
174. Marinkovic, P., Reuter, M.S., Brill, M.S., Godinho, L., Kerschensteiner, M., Misgeld, T., Axonal transport deficits and degeneration can evolve independently in mouse models of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 4296–4301.
175. Martin, N., Jaubert, J., Gounon, P., Salido, E., Haase, G., Szatanik, M., Guenet, J.L., A missense mutation in Tbce causes progressive motor neuronopathy in mice. Nat. Genet. 32 (2002), 443–447.
176. Matamoros, A.J., Baas, P.W., Microtubules in health and degenerative disease of the nervous system. Brain Res. Bull. 126 (2016), 217–225.
177. Mattiazzi, M., D'Aurelio, M., Gajewski, C.D., Martushova, K., Kiaei, M., Beal, M.F., Manfredi, G., Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J. Biol. Chem. 277 (2002), 29626–29633.
178. May, S., et al. C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration. Acta Neuropathol. 128 (2014), 485–503.
179. McDermott, C.J., Grierson, A.J., Wood, J.D., Bingley, M., Wharton, S.B., Bushby, K.M., Shaw, P.J., Hereditary spastic paraparesis: disrupted intracellular transport associated with spastin mutation. Ann. Neurol. 54 (2003), 748–759.
180. Meyerowitz, J., et al. C-Jun N-terminal kinase controls TDP-43 accumulation in stress granules induced by oxidative stress. Mol. Neurodegener., 6, 2011, 57.
181. Milde, S., Adalbert, R., Elaman, M.H., Coleman, M.P., Axonal transport declines with age in two distinct phases separated by a period of relative stability. Neurobiol. Aging 36 (2015), 971–981.
182. Millecamps, S., Julien, J.P., Axonal transport deficits and neurodegenerative diseases. Nat. Rev. Neurosci. 14 (2013), 161–176.
183. Mitne-Neto, M., et al. Downregulation of VAPB expression in motor neurons derived from induced pluripotent stem cells of ALS8 patients. Hum. Mol. Genet. 20 (2011), 3642–3652.
184. Morfini, G., Szebenyi, G., Elluru, R., Ratner, N., Brady, S.T., Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility. EMBO J. 21 (2002), 281–293.
185. Morfini, G., Szebenyi, G., Brown, H., Pant, H.C., Pigino, G., DeBoer, S., Beffert, U., Brady, S.T., A novel CDK5-dependent pathway for regulating GSK3 activity and kinesin-driven motility in neurons. EMBO J. 23 (2004), 2235–2245.
186. Morfini, G., Pigino, G., Szebenyi, G., You, Y., Pollema, S., Brady, S.T., JNK mediates pathogenic effects of polyglutamine-expanded androgen receptor on fast axonal transport. Nat. Neurosci. 9 (2006), 907–916.
187. Morfini, G.A., et al. Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin. Nat. Neurosci. 12 (2009), 864–871.
188. Morfini, G.A., et al. Inhibition of fast axonal transport by pathogenic SOD1 involves activation of p38 MAP kinase. PLoS One, 8, 2013, e65235.
189. Morlino, G., et al. Miro-1 links mitochondria and microtubule Dynein motors to control lymphocyte migration and polarity. Mol. Cell. Biol. 34 (2014), 1412–1426.
190. Morotz, G.M., De Vos, K.J., Vagnoni, A., Ackerley, S., Shaw, C.E., Miller, C.C., Amyotrophic lateral sclerosis-associated mutant VAPBP56S perturbs calcium homeostasis to disrupt axonal transport of mitochondria. Hum. Mol. Genet. 21 (2012), 1979–1988.
191. Muglia, M., et al. A novel KIF5A mutation in an Italian family marked by spastic paraparesis and congenital deafness. J. Neurol. Sci. 343 (2014), 218–220.
192. Munch, C., et al. Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. Neurology 63 (2004), 724–726.
193. Munch, C., et al. Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD. Ann. Neurol. 58 (2005), 777–780.
194. Nagy, M., Fenton, W.A., Li, D., Furtak, K., Horwich, A.L., Extended survival of misfolded G85R SOD1-linked ALS mice by transgenic expression of chaperone Hsp110. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), 5424–5428.
195. Nangaku, M., Sato-Yoshitake, R., Okada, Y., Noda, Y., Takemura, R., Yamazaki, H., Hirokawa, N., KIF1B, a novel microtubule plus end-directed monomeric motor protein for transport of mitochondria. Cell 79 (1994), 1209–1220.
196. Nguyen, M.D., Larivière, R.C., Julien, J.-P., Deregulation of Cdk5 in a mouse model of ALS. Neuron 30 (2001), 135–148.
197. Niwa, S., Tanaka, Y., Hirokawa, N., KIF1Bbeta- and KIF1A-mediated axonal transport of presynaptic regulator Rab3 occurs in a GTP-dependent manner through DENN/MADD. Nat. Cell Biol. 10 (2008), 1269–1279.
198. Norkett, R., Modi, S., Birsa, N., Atkin, T.A., Ivankovic, D., Pathania, M., Trossbach, S.V., Korth, C., Hirst, W.D., Kittler, J.T., DISC1-dependent regulation of mitochondrial dynamics controls the morphogenesis of complex neuronal dendrites. J. Biol. Chem. 291 (2016), 613–629.
199. North, B.J., Marshall, B.L., Borra, M.T., Denu, J.M., Verdin, E., The human Sir2 Ortholog, SIRT2, is an NAD +−dependent tubulin deacetylase. Mol. Cell 11 (2003), 437–444.
200. Ogawa, F., Malavasi, E.L., Crummie, D.K., Eykelenboom, J.E., Soares, D.C., Mackie, S., Porteous, D.J., Millar, J.K., DISC1 complexes with TRAK1 and Miro1 to modulate anterograde axonal mitochondrial trafficking. Hum. Mol. Genet. 23 (2014), 906–919.
201. Ogawa, F., Murphy, L.C., Malavasi, E.L., O'Sullivan, S.T., Torrance, H.S., Porteous, D.J., Millar, J.K., NDE1 and GSK3β associate with TRAK1 and regulate axonal mitochondrial motility: identification of cyclic AMP as a novel modulator of axonal mitochondrial trafficking. ACS Chem. Neurosci. 7 (2016), 553–564.
202. Okada, Y., Yamazaki, H., Sekine-Aizawa, Y., Hirokawa, N., The neuron-specific kinesin superfamily protein KIF1A is a unique monomeric motor for anterograde axonal transport of synaptic vesicle precursors. Cell 81 (1995), 769–780.
203. Ori-McKenney, K.M., Xu, J., Gross, S.P., Vallee, R.B., A dynein tail mutation impairs motor processivity. Nat. Cell Biol. 12 (2010), 1228–1234.
204. Paillusson, S., Stoica, R., Gomez-Suaga, P., Lau, D.H., Mueller, S., Miller, T., Miller, C.C., There's something wrong with my MAM; the ER-mitochondria axis and neurodegenerative diseases. Trends Neurosci. 39 (2016), 146–157.
205. Panda, D., Jordan, M.A., Chu, K.C., Wilson, L., Differential effects of vinblastine on polymerization and dynamics at opposite microtubule ends. J. Biol. Chem. 271 (1996), 29807–29812.
206. Parakh, S., Atkin, J.D., Protein folding alterations in amyotrophic lateral sclerosis. Brain Res. 1648 (2016), 633–649.
207. Park, Y.U., Jeong, J., Lee, H., Mun, J.Y., Kim, J.H., Lee, J.S., Nguyen, M.D., Han, S.S., Suh, P.G., Park, S.K., Disrupted-in-schizophrenia 1 (DISC1) plays essential roles in mitochondria in collaboration with Mitofilin. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 17785–17790.
208. Park, C., et al. Disrupted-in-schizophrenia 1 (DISC1) and Syntaphilin collaborate to modulate axonal mitochondrial anchoring. Mol. Brain, 9, 2016, 69.
209. Pasinelli, P., Belford, M.E., Lennon, N., Bacskai, B.J., Hyman, B.T., Trotti, D., Brown, R.H.J., Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron 43 (2004), 19–30.
210. Patrick, G.N., Zukerberg, L., Nikolic, M., de la Monte, S., Dikkes, P., Tsai, L.H., Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402 (1999), 615–622.
211. Perez-Branguli, F., et al. Dysfunction of spatacsin leads to axonal pathology in SPG11-linked hereditary spastic paraplegia. Hum. Mol. Genet. 23 (2014), 4859–4874.
212. Perlson, E., Jeong, G.B., Ross, J.L., Dixit, R., Wallace, K.E., Kalb, R.G., Holzbaur, E.L., A switch in retrograde signaling from survival to stress in rapid-onset neurodegeneration. J. Neurosci. 29 (2009), 9903–9917.
213. Perrot, R., Julien, J.P., Real-time imaging reveals defects of fast axonal transport induced by disorganization of intermediate filaments. FASEB J. 23 (2009), 3213–3225.
214. Pickles, S., Destroismaisons, L., Peyrard, S.L., Cadot, S., Rouleau, G.A., Brown, R.H., Julien, J.P., Arbour, N., Vande Velde, C., Mitochondrial damage revealed by immunoselection for ALS-linked misfolded SOD1. Hum. Mol. Genet. 22 (2013), 3947–3959.
215. Pickles, S., Semmler, S., Broom, H.R., Destroismaisons, L., Legroux, L., Arbour, N., Meiering, E., Cashman, N.R., Vande Velde, C., ALS-linked misfolded SOD1 species have divergent impacts on mitochondria. Acta Neuropathol. Commun., 4, 2016, 43.
216. Piñero-Martos, E., Ortega-Vila, B., Pol-Fuster, J., Cisneros-Barroso, E., Ruiz-Guerra, L., Medina-Dols, A., Heine-Suñer, D., Lladó, J., Olmos, G., Vives-Bauzà, C., Disrupted in schizophrenia 1 (DISC1) is a constituent of the mammalian mitochondrial contact site and cristae organizing system (MICOS) complex, and is essential for oxidative phosphorylation. Hum. Mol. Genet., ddw250, 2016, 10.1093/hmg/ddw250.
217. Pizzasegola, C., Caron, I., Daleno, C., Ronchi, A., Minoia, C., Carrì, M.T., Bendotti, C., Treatment with lithium carbonate does not improve disease progression in two different strains of SOD1 mutant mice. Amyotroph. Lateral Scler. 10 (2009), 221–228.
218. Puls, I., et al. Mutant dynactin in motor neuron disease. Nat. Genet. 33 (2003), 455–456.
219. Puls, I., et al. Distal spinal and bulbar muscular atrophy caused by dynactin mutation. Ann. Neurol. 57 (2005), 687–694.
220. Rao, M.V., Campbell, J., Palaniappan, A., Kumar, A., Nixon, R.A., Calpastatin inhibits motor neuron death and increases survival of hSOD1(G93A) mice. J. Neurochem. 137 (2016), 253–265.
221. Reed, N.A., Cai, D., Blasius, T.L., Jih, G.T., Meyhofer, E., Gaertig, J., Verhey, K.J., Microtubule acetylation promotes kinesin-1 binding and transport. Curr. Biol. 16 (2006), 2166–2172.
222. Renton, A.E., Chio, A., Traynor, B.J., State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 17 (2014), 17–23.
223. Rodríguez-Martín, T., Pooler, A.M., Lau, D.H., Mórotz, G.M., De Vos, K.J., Gilley, J., Coleman, M.P., Hanger, D.P., Reduced number of axonal mitochondria and tau hypophosphorylation in mouse P301L tau knockin neurons. Neurobiol. Dis. 85 (2016), 1–10.
224. Rouleau, G.A., Clark, A.W., Rooke, K., Pramatarova, A., Krizus, A., Suchowersky, O., Julien, J.P., Figlewicz, D., SOD1 mutation is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis. Ann. Neurol. 39 (1996), 128–131.
225. Russo, G.J., Louie, K., Wellington, A., Macleod, G.T., Hu, F., Panchumarthi, S., Zinsmaier, K.E., Drosophila Miro is required for both anterograde and retrograde axonal mitochondrial transport. J. Neurosci. 29 (2009), 5443–5455.
226. Saotome, M., Safiulina, D., Szabadkai, G., Das, S., Fransson, A., Aspenstrom, P., Rizzuto, R., Hajnóczky, G., Bidirectional Ca2 +-dependent control of mitochondrial dynamics by the Miro GTPase. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 20728–20733.
227. Sasaki, S., Iwata, M., Ultrastructural study of synapses in the anterior horn neurons of patients with amyotrophic lateral sclerosis. Neurosci. Lett. 204 (1996), 53–56.
228. Sasaki, S., Iwata, M., Mitochondrial alterations in the spinal cord of patients with sporadic amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 66 (2007), 10–16.
229. Schäfer, M.K., Bellouze, S., Jacquier, A., Schaller, S., Richard, L., Mathis, S., Vallat, J.M., Haase, G., Sensory neuropathy in progressive motor neuronopathy (pmn) mice is associated with defects in microtubule polymerization and axonal transport. Brain Pathol., 2016, 10.1111/bpa.12422.
230. Schiavo, G., Greensmith, L., Hafezparast, M., Fisher, E.M., Cytoplasmic dynein heavy chain: the servant of many masters. Trends Neurosci. 36 (2013), 641–651.
231. Schmieg, N., Menendez, G., Schiavo, G., Terenzio, M., Signalling endosomes in axonal transport: travel updates on the molecular highway. Semin. Cell Dev. Biol. 27 (2014), 32–43.
232. Schwarzschild, M.A., Cole, R.L., Hyman, S.E., Glutamate, but not dopamine, stimulates stress-activated protein kinase and AP-1-mediated transcription in striatal neurons. J. Neurosci. 17 (1997), 3455–3466.
233. Schwenk, B.M., et al. The FTLD risk factor TMEM106B and MAP6 control dendritic trafficking of lysosomes. EMBO J. 33 (2014), 450–467.
234. Scoto, M., et al. Novel mutations expand the clinical spectrum of DYNC1H1-associated spinal muscular atrophy. Neurology 84 (2015), 668–679.
235. Seitz, A., Single-molecule investigation of the interference between kinesin, tau and MAP2c. EMBO J. 21 (2002), 4896–4905.
236. Sendtner, M., Holtmann, B., Hughes, R.A., The response of motoneurons to neurotrophins. Neurochem. Res. 21 (1996), 831–841.
237. Shea, T.B., Yabe, J.T., Ortiz, D., Pimenta, A., Loomis, P., Goldman, R.D., Amin, N., Pant, H.C., Cdk5 regulates axonal transport and phosphorylation of neurofilaments in cultured neurons. J. Cell Sci. 117 (2004), 933–941.
238. Shea, T.B., Zheng, Y.L., Ortiz, D., Pant, H.C., Cyclin-dependent kinase 5 increases perikaryal neurofilament phosphorylation and inhibits neurofilament axonal transport in response to oxidative stress. J. Neurosci. Res. 76 (2004), 795–800.
239. Shida, T., Cueva, J.G., Xu, Z., Goodman, M.B., Nachury, M.V., The major alpha-tubulin K40 acetyltransferase alphaTAT1 promotes rapid ciliogenesis and efficient mechanosensation. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 21517–21522.
240. Shlevkov, E., Kramer, T., Schapansky, J., LaVoie, M.J., Schwarz, T.L., Miro phosphorylation sites regulate Parkin recruitment and mitochondrial motility. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), E6097–E6106.
241. Siklos, L., Engelhardt, J., Harati, Y., Smith, R.G., Joo, F., Appel, S.H., Ultrastructural evidence for altered calcium in motor nerve terminals in amyotropic lateral sclerosis. Ann. Neurol. 39 (1996), 203–216.
242. Siklós, L., Engelhardt, J.I., Alexianu, M.E., Gurney, M.E., Siddique, T., Appel, S.H., Intracellular calcium parallels motoneuron degeneration in SOD-1 mutant mice. J. Neuropathol. Exp. Neurol. 57 (1998), 571–587.
243. Slaughter, T., Black, M.M., STOP (stable-tubule-only-polypeptide) is preferentially associated with the stable domain of axonal microtubules. J. Neurocytol. 32 (2003), 399–413.
244. Smith, B., et al. Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS. Neuron 84 (2014), 324–331.
245. Song, Y., Kirkpatrick, L.L., Schilling, A.B., Helseth, D.L., Chabot, N., Keillor, J.W., Johnson, G.V., Brady, S.T., Transglutaminase and polyamination of tubulin: posttranslational modification for stabilizing axonal microtubules. Neuron 78 (2013), 109–123.
246. Song, Y., Nagy, M., Ni, W., Tyagi, N.K., Fenton, W.A., López-Giráldez, F., Overton, J.D., Horwich, A.L., Brady, S.T., Molecular chaperone Hsp110 rescues a vesicle transport defect produced by an ALS-associated mutant SOD1 protein in squid axoplasm. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 5428–5433.
247. van Spronsen, M., et al. TRAK/Milton motor-adaptor proteins steer mitochondrial trafficking to axons and dendrites. Neuron 77 (2013), 485–502.
248. Stagi, M., Gorlovoy, P., Larionov, S., Takahashi, K., Neumann, H., Unloading kinesin transported cargoes from the tubulin track via the inflammatory c-Jun N-terminal kinase pathway. FASEB J. 20 (2006), 2573–2575.
249. Stamer, K., Vogel, R., Thies, E., Mandelkow, E., Mandelkow, E.M., Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J. Cell Biol. 156 (2002), 1051–1063.
250. Stanton, R.A., Gernert, K.M., Nettles, J.H., Aneja, R., Drugs that target dynamic microtubules: a new molecular perspective. Med. Res. Rev. 31 (2011), 443–481.
251. Stavoe, A.K., Hill, S.E., Hall, D.H., Colón-Ramos, D.A., KIF1A/UNC-104 transports ATG-9 to regulate neurodevelopment and autophagy at synapses. Dev. Cell 38 (2016), 171–185.
252. Stephen, T.L., Higgs, N.F., Sheehan, D.F., Al Awabdh, S., López-Doménech, G., Arancibia-Carcamo, I.L., Kittler, J.T., Miro1 regulates activity-driven positioning of mitochondria within astrocytic processes apposed to synapses to regulate intracellular calcium signaling. J. Neurosci. 35 (2015), 15996–16011.
253. Stevenson, A., Yates, D.M., Manser, C., De Vos, K.J., Vagnoni, A., Leigh, P.N., McLoughlin, D.M., Miller, C.C., Riluzole protects against glutamate-induced slowing of neurofilament axonal transport. Neurosci. Lett. 454 (2009), 161–164.
254. Stoica, R., et al. ER-mitochondria associations are regulated by the VAPB-PTPIP51 interaction and are disrupted by ALS/FTD-associated TDP-43. Nat. Commun., 5, 2014, 3996.
255. Stoica, R., et al. ALS/FTD-associated FUS activates GSK-3β to disrupt the VAPB-PTPIP51 interaction and ER-mitochondria associations. EMBO Rep. 17 (2016), 1326–1342.
256. Stowers, R.S., Megeath, L.J., Gorska-Andrzejak, J., Meinertzhagen, I.A., Schwarz, T.L., Axonal transport of mitochondria to synapses depends on milton, a novel Drosophila protein. Neuron 36 (2002), 1063–1077.
257. Strom, A.L., Shi, P., Zhang, F., Gal, J., Kilty, R., Hayward, L.J., Zhu, H., Interaction of amyotrophic lateral sclerosis (ALS)-related mutant copper-zinc superoxide dismutase with the dynein-dynactin complex contributes to inclusion formation. J. Biol. Chem. 283 (2008), 22795–22805.
258. Strong, M.J., Volkening, K., Hammond, R., Yang, W., Strong, W., Leystra-Lantz, C., Shoesmith, C., TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein. Mol. Cell. Neurosci. 35 (2007), 320–327.
259. Suzuki, H., Matsuoka, M., The JNK/c-Jun signaling axis contributes to the TDP-43-induced cell death. Mol. Cell. Biochem. 372 (2013), 241–248.
260. Swarup, V., Phaneuf, D., Bareil, C., Robertson, J., Rouleau, G.A., Kriz, J., Julien, J.P., Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments. Brain 134 (2011), 2610–2626.
261. Szebenyi, G., et al. Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport. Neuron 40 (2003), 41–52.
262. Taes, I., Timmers, M., Hersmus, N., Bento-Abreu, A., Van Den Bosch, L., Van Damme, P., Auwerx, J., Robberecht, W., Hdac6 deletion delays disease progression in the SOD1G93A mouse model of ALS. Hum. Mol. Genet. 22 (2013), 1783–1790.
263. Takahashi, S., Kulkarni, A.B., Mutant superoxide dismutase 1 causes motor neuron degeneration independent of cyclin-dependent kinase 5 activation by p35 or p25. J. Neurochem. 88 (2004), 1295–1304.
264. Takeuchi, H., Mizuno, T., Zhang, G., Wang, J., Kawanokuchi, J., Kuno, R., Suzumura, A., Neuritic beading induced by activated microglia is an early feature of neuronal dysfunction toward neuronal death by inhibition of mitochondrial respiration and axonal transport. J. Biol. Chem. 280 (2005), 10444–10454.
265. Tan, W., Pasinelli, P., Trotti, D., Role of mitochondria in mutant SOD1 linked amyotrophic lateral sclerosis. Biochim. Biophys. Acta 1842 (2014), 1295–1301.
266. Tanaka, Y., Niwa, S., Dong, M., Farkhondeh, A., Wang, L., Zhou, R., Hirokawa, N., The molecular motor KIF1A transports the TrkA neurotrophin receptor and is essential for sensory neuron survival and function. Neuron 90 (2016), 1215–1229.
267. Tarrade, A., et al. A mutation of spastin is responsible for swellings and impairment of transport in a region of axon characterized by changes in microtubule composition. Hum. Mol. Genet. 15 (2006), 3544–3558.
268. Teuchert, M., Fischer, D., Schwalenstoecker, B., Habisch, H.J., Bockers, T.M., Ludolph, A.C., A dynein mutation attenuates motor neuron degeneration in SOD1(G93A) mice. Exp. Neurol. 198 (2006), 271–274.
269. Teuling, E., van Dis, V., Wulf, P.S., Haasdijk, E.D., Akhmanova, A., Hoogenraad, C.C., Jaarsma, D., A novel mouse model with impaired dynein/dynactin function develops amyotrophic lateral sclerosis (ALS)-like features in motor neurons and improves lifespan in SOD1-ALS mice. Hum. Mol. Genet. 17 (2008), 2849–2862.
270. Tortarolo, M., Veglianese, P., Calvaresi, N., Botturi, A., Rossi, C., Giorgini, A., Migheli, A., Bendotti, C., Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression. Mol. Cell. Neurosci. 23 (2003), 180–192.
271. Toyoshima, I., Sugawara, M., Kato, K., Wada, C., Hirota, K., Hasegawa, K., Kowa, H., Sheetz, M.P., Masamune, O., Kinesin and dynein in spinal spheroids with motor neuron disease. J. Neurol. Sci. 159 (1998), 38–44.
272. Trinczek, B., Ebneth, A., Mandelkow, E., Tau regulates the attachment/detachment but not the speed of motors in microtubule-dependent transport of single vesicles and organelles. J. Cell Sci. 112 (1999), 2355–2367.
273. Trotta, N., Orso, G., Rossetto, M.G., Daga, A., Broadie, K., The hereditary spastic paraplegia gene, spastin, regulates microtubule stability to modulate synaptic structure and function. Curr. Biol. 14 (2004), 1135–1147.
274. Ugolino, J., Ji, Y.J., Conchina, K., Chu, J., Nirujogi, R.S., Pandey, A., Brady, N.R., Hamacher-Brady, A., Wang, J., Loss of C9orf72 enhances autophagic activity via deregulated mTOR and TFEB signaling. PLoS Genet., 12, 2016, e1006443.
275. UKMND-LiCALS, S.G., et al. Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 12 (2013), 339–345.
276. Urwin, H., et al. Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations. Hum. Mol. Genet. 19 (2010), 2228–2238.
277. Vagnoni, A., Hoffmann, P.C., Bullock, S.L., Reducing Lissencephaly-1 levels augments mitochondrial transport and has a protective effect in adult Drosophila neurons. J. Cell Sci. 129 (2016), 178–190.
278. Van Deerlin, V.M., et al. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat. Genet. 42 (2010), 234–239.
279. Vande Velde, C., McDonald, K.K., Boukhedimi, Y., McAlonis-Downes, M., Lobsiger, C.S., Bel Hadj, S., Zandona, A., Julien, J.P., Shah, S.B., Cleveland, D.W., Misfolded SOD1 associated with motor neuron mitochondria alters mitochondrial shape and distribution prior to clinical onset. PLoS One, 6, 2011, e22031.
280. Vilariño-Güell, C., et al. Characterization of DCTN1 genetic variability in neurodegeneration. Neurology 72 (2009), 2024–2028.
281. Vogel, F., Bornhövd, C., Neupert, W., Reichert, A.S., Dynamic subcompartmentalization of the mitochondrial inner membrane. J. Cell Biol. 175 (2006), 237–247.
282. Wagner, U., Utton, M., Gallo, J.M., Miller, C.C., Cellular phosphorylation of tau by GSK-3 beta influences tau binding to microtubules and microtubule organisation. J. Cell Sci. 109 (1996), 1537–1543.
283. Wang, X., Schwarz, T.L., The mechanism of Ca2 +-dependent regulation of kinesin-mediated mitochondrial motility. Cell 136 (2009), 163–174.
284. Wang, X., Winter, D., Ashrafi, G., Schlehe, J., Wong, Y.L., Selkoe, D., Rice, S., Steen, J., LaVoie, M.J., Schwarz, T.L., PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell 147 (2011), 893–906.
285. Wang, W., Li, L., Lin, W.L., Dickson, D.W., Petrucelli, L., Zhang, T., Wang, X., The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons. Hum. Mol. Genet. 22 (2013), 4706–4719.
286. Wang, W., et al. The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity. Nat. Med. 22 (2016), 869–878.
287. Warita, H., Itoyama, Y., Abe, K., Selective impairment of fast anterograde axonal transport in the peripheral nerves of asymptomatic transgenic mice with a G93A mutant SOD1 gene. Brain Res. 819 (1999), 120–131.
288. Watanabe, S., Ilieva, H., Tamada, H., Nomura, H., Komine, O., Endo, F., Jin, S., Mancias, P., Kiyama, H., Yamanaka, K., Mitochondria-associated membrane collapse is a common pathomechanism in SIGMAR1- and SOD1-linked ALS. EMBO Mol. Med. 8 (2016), 1421–1437.
289. Webster, C.P., et al. The C9orf72 protein interacts with Rab1a and the ULK1 complex to regulate initiation of autophagy. EMBO J. 35 (2016), 1656–1676.
290. Webster, C.P., Smith, E.F., Grierson, A.J., De Vos, K.J., C9orf72 plays a central role in Rab GTPase-dependent regulation of autophagy. Small GTPases, 2016, 1–10.
291. Weihofen, A., Thomas, K.J., Ostaszewski, B.L., Cookson, M.R., Selkoe, D.J., Pink1 forms a multiprotein complex with Miro and Milton, linking Pink1 function to mitochondrial trafficking. Biochemistry 48 (2009), 2045–2052.
292. Williamson, T.L., Cleveland, D.W., Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat. Neurosci. 2 (1999), 50–56.
293. Wood, J.D., Landers, J.A., Bingley, M., McDermott, C.J., Thomas-McArthur, V., Gleadall, L.J., Shaw, P.J., Cunliffe, V.T., The microtubule-severing protein Spastin is essential for axon outgrowth in the zebrafish embryo. Hum. Mol. Genet. 15 (2006), 2763–2771.
294. Xia, C.H., Roberts, E.A., Her, L.S., Liu, X., Williams, D.S., Cleveland, D.W., Goldstein, L.S., Abnormal neurofilament transport caused by targeted disruption of neuronal kinesin heavy chain KIF5A. J. Cell Biol. 161 (2003), 55–66.
295. Xia, Q., Wang, H., Zhang, Y., Ying, Z., Wang, G., Loss of TDP-43 inhibits amyotrophic lateral sclerosis-linked mutant SOD1 aggresome formation in an HDAC6-dependent manner. J. Alzheimers Dis. 45 (2015), 373–386.
296. Xia, Q., et al. TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion. EMBO J. 35 (2015), 121–142.
297. Xiao, S., McLean, J., Robertson, J., Neuronal intermediate filaments and ALS: a new look at an old question. Biochim. Biophys. Acta 1762 (2006), 1001–1012.
298. Xu, Y.F., et al. Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. J. Neurosci. 30 (2010), 10851–10859.
299. Xu, Y.F., Zhang, Y.J., Lin, W.L., Cao, X., Stetler, C., Dickson, D.W., Lewis, J., Petrucelli, L., Expression of mutant TDP-43 induces neuronal dysfunction in transgenic mice. Mol. Neurodegener., 6, 2011, 73.
300. Yadav, P., et al. Neurofilament depletion improves microtubule dynamics via modulation of Stat3/stathmin signaling. Acta Neuropathol. 132 (2016), 93–110.
301. Yan, Q., Elliott, J.L., Matheson, C., Sun, J., Zhang, L., Mu, X., Rex, K.L., Snider, W.D., Influences of neurotrophins on mammalian motoneurons in vivo. J. Neurobiol. 24 (1993), 1555–1577.
302. Yan, S., Guo, C., Hou, G., Zhang, H., Lu, X., Williams, J.C., Polenova, T., Atomic-resolution structure of the CAP-Gly domain of dynactin on polymeric microtubules determined by magic angle spinning NMR spectroscopy. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 14611–14616.
303. Yang, W., Leystra-Lantz, C., Strong, M.J., Upregulation of GSK3beta expression in frontal and temporal cortex in ALS with cognitive impairment (ALSci). Brain Res. 1196 (2008), 131–139.
304. Yang, M., Liang, C., Swaminathan, K., Herrlinger, S., Lai, F., Shiekhattar, R., Chen, J.-F., A C9ORF72/SMCR8-containing complex regulates ULK1 and plays a dual role in autophagy. Sci. Adv., 2, 2016, e1601167.
305. d'Ydewalle, C., Krishnan, J., Chiheb, D.M., Van Damme, P., Irobi, J., Kozikowski, A.P., Vanden Berghe, P., Timmerman, V., Robberecht, W., Van Den Bosch, L., HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease. Nat. Med. 17 (2011), 968–974.
306. Yonekawa, Y., Harada, A., Okada, Y., Funakoshi, T., Kanai, Y., Takei, Y., Terada, S., Noda, T., Hirokawa, N., Defect in synaptic vesicle precursor transport and neuronal cell death in KIF1A motor protein-deficient mice. J. Cell Biol. 141 (1998), 431–441.
307. Yu, L., Guan, Y., Wu, X., Chen, Y., Liu, Z., Du, H., Wang, X., Wnt Signaling is altered by spinal cord neuronal dysfunction in amyotrophic lateral sclerosis transgenic mice. Neurochem. Res. 38 (2013), 1904–1913.
308. Zala, D., Hinckelmann, M.V., Yu, H., Lyra da Cunha, M.M., Liot, G., Cordelieres, F.P., Marco, S., Saudou, F., Vesicular glycolysis provides on-board energy for fast axonal transport. Cell 152 (2013), 479–491.
309. Zhan, L., Xie, Q., Tibbetts, R.S., Opposing roles of p38 and JNK in a Drosophila model of TDP-43 proteinopathy reveal oxidative stress and innate immunity as pathogenic components of neurodegeneration. Hum. Mol. Genet. 24 (2015), 757–772.
310. Zhang, F., Zhu, H., Intracellular conformational alterations of mutant SOD1 and the implications for fALS-associated SOD1 mutant induced motor neuron cell death. Biochim. Biophys. Acta 1760 (2006), 404–414.
311. Zhang, B., Tu, P., Abtahian, F., Trojanowski, J.Q., Lee, V.M., Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation. J. Cell Biol. 139 (1997), 1307–1315.
312. Zhang, B., Higuchi, M., Yoshiyama, Y., Ishihara, T., Forman, M.S., Martinez, D., Joyce, S., Trojanowski, J.Q., Lee, V.M., Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy. J. Neurosci. 24 (2004), 4657–4667.
313. Zhang, F., Strom, A.L., Fukada, K., Lee, S., Hayward, L.J., Zhu, H., Interaction between familial amyotrophic lateral sclerosis (ALS)-linked SOD1 mutants and the dynein complex. J. Biol. Chem. 282 (2007), 16691–16699.
314. Zhang, F., Wang, W., Siedlak, S.L., Liu, Y., Liu, J., Jiang, K., Perry, G., Zhu, X., Wang, X., Miro1 deficiency in amyotrophic lateral sclerosis. Front. Aging Neurosci., 7, 2015, 100.
315. Zhu, Y.B., Sheng, Z.H., Increased axonal mitochondrial mobility does not slow amyotrophic lateral sclerosis (ALS)-like disease in mutant SOD1 mice. J. Biol. Chem. 286 (2011), 23432–23440.